MongoDB slides 6.7% as investors digest post-earnings guidance reset and fresh target cuts

MongoDB, Inc. (MDB) is down 6.7% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to continued fallout from MongoDB’s recent outlook, which tempered near-term growth expectations despite a quarterly beat. Ongoing analyst price-target cuts and commentary around decelerating Atlas growth likely kept pressure on the shares.

Details:

MongoDB’s latest quarterly results topped expectations, but management’s forward guidance set a lower bar for near-term revenue growth than many investors had been positioned for.

Several Wall Street firms have recently lowered price targets and/or shifted to more neutral stances after the company’s outlook update, reinforcing the “guidance reset” narrative.

Company disclosures highlighted that Atlas (its cloud database offering) growth has been slowing versus prior periods, which can weigh on valuation for a premium-growth software name.

This could also be because some investors are cautious around cloud-service reliability headlines after recent Atlas service-impact updates tied to an underlying cloud provider issue in a specific region.

Sources:

MongoDB Investor Relations, MarketBeat, Investing.com, MongoDB Cloud Status

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$MDB Insider Trading Activity

$MDB insiders have traded $MDB stock on the open market 55 times in the past 6 months. Of those trades, 0 have been purchases and 55 have been sales.

Here’s a breakdown of recent trading of $MDB stock by insiders over the last 6 months:

DWIGHT A MERRIMAN has made 0 purchases and 36 sales selling 92,583 shares for an estimated $34,449,417.
ROELOF BOTHA has made 0 purchases and 11 sales selling 24,850 shares for an estimated $10,085,418.
HOPE F COCHRAN has made 0 purchases and 3 sales selling 4,132 shares for an estimated $1,461,097.
CHARLES M JR HAZARD has made 0 purchases and 4 sales selling 1,998 shares for an estimated $709,140.
THOMAS BULL (Chief Accounting Officer) sold 555 shares for an estimated $229,692

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$MDB Hedge Fund Activity

We have seen 486 institutional investors add shares of $MDB stock to their portfolio, and 364 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,980,978 shares (-77.5%) from their portfolio in Q4 2025, for an estimated $1,670,776,656
MORGAN STANLEY removed 1,338,682 shares (-49.2%) from their portfolio in Q4 2025, for an estimated $561,831,448
AMUNDI removed 1,163,837 shares (-78.5%) from their portfolio in Q4 2025, for an estimated $488,450,750
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 825,895 shares (+229.1%) to their portfolio in Q4 2025, for an estimated $346,619,872
BLACKROCK, INC. added 799,661 shares (+16.0%) to their portfolio in Q4 2025, for an estimated $335,609,725
FIL LTD removed 712,218 shares (-59.9%) from their portfolio in Q4 2025, for an estimated $298,910,772
VALUEACT HOLDINGS, L.P. removed 711,400 shares (-33.6%) from their portfolio in Q4 2025, for an estimated $298,567,466

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$MDB Congressional Stock Trading

Members of Congress have traded $MDB stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $MDB stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$MDB Analyst Ratings

Wall Street analysts have issued reports on $MDB in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 01/20/2026
RBC Capital issued a "Outperform" rating on 01/05/2026
Argus Research issued a "Buy" rating on 12/04/2025
Piper Sandler issued a "Overweight" rating on 12/02/2025
Oppenheimer issued a "Outperform" rating on 12/02/2025
DA Davidson issued a "Buy" rating on 12/02/2025
Canaccord Genuity issued a "Buy" rating on 12/02/2025

To track analyst ratings and price targets for $MDB, check out Quiver Quantitative's $MDB forecast page.

$MDB Price Targets

Multiple analysts have issued price targets for $MDB recently. We have seen 28 analysts offer price targets for $MDB in the last 6 months, with a median target of $376.5.

Here are some recent targets:

Matthew Broome from Mizuho set a target price of $325.0 on 03/23/2026
Patrick Colville from Scotiabank set a target price of $310.0 on 03/05/2026
Kash Rangan from Goldman Sachs set a target price of $320.0 on 03/04/2026
Ryan Macwilliams from Wells Fargo set a target price of $375.0 on 03/03/2026
Firoz Valliji from Bernstein set a target price of $428.0 on 03/03/2026
Mike Cikos from Needham set a target price of $300.0 on 03/03/2026
William Power from Baird set a target price of $260.0 on 03/03/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.